Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nutrien Ltd (NTR) vs GeneDx Holdings Corp (WGS) Price & Performance

Nutrien LtdTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Nutrien Ltd vs GeneDx Holdings Corp — how do they compare? Nutrien Ltd trades at $66.6 (market cap $32.05B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Nutrien Ltd is far larger — about 13.1× GeneDx Holdings Corp's market cap, and Nutrien Ltd pays a 3.27% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

NTRWGS
Market Cap
$32.05B$2.44B
Sector
Basic MaterialsTechnology
52-Week High
$83.94$167.51
52-Week Low
$53.64$34.51
Enterprise Value
$43.86B$2.48B
Dividend Yield
3.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nutrien Ltd

Nutrien (NTR) trades at $66.85, up 0.81% today, with a bearish technical signal despite neutral oscillators. Recent Q2 2026 earnings missed EPS estimates but beat on revenue, driven by higher potash prices. The company maintains a stable dividend of $0.55 per share and shows improving net income margins, though cash flow trends have weakened. Analyst consensus is bullish with a $76.17 price target, highlighting structural advantages in nitrogen assets.

The outlook is mixed: strong fundamentals and analyst support suggest upside, but technical weakness and volatile earnings pose risks. Key opportunities include exposure to agricultural cycles and cost advantages; risks involve input cost pressures and execution challenges in a competitive fertilizer market.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.

Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nutrien Ltd

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

Read more on NTR

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS